Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - DYNAVAX TECHNOLOGIES CORPFinancial_Report.xls
10-K - FORM 10-K - DYNAVAX TECHNOLOGIES CORPd274776d10k.htm
EX-23.1 - CONSENT ON INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - DYNAVAX TECHNOLOGIES CORPd274776dex231.htm
EX-21.1 - LIST OF SUBSIDIARIES - DYNAVAX TECHNOLOGIES CORPd274776dex211.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - DYNAVAX TECHNOLOGIES CORPd274776dex311.htm
EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 - DYNAVAX TECHNOLOGIES CORPd274776dex312.htm
EX-32.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 - DYNAVAX TECHNOLOGIES CORPd274776dex321.htm
EX-10.67 - AMD NO. 4 TO THE AGREEMENT BETWEEN ASTRAZENECA AB & DYNAVAX TECHNOLOGIES CORP. - DYNAVAX TECHNOLOGIES CORPd274776dex1067.htm

Exhibit 32.2

Certification Pursuant to Section 1350 of Chapter 63

of Title 18 of the United States Code

I, Jennifer Lew, hereby certify, pursuant to 18 U.S.C § 1350, as adopted pursuant to Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and to § 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of Dynavax Technologies Corporation (the “Company”), that, to the best of my knowledge:

(i) The Annual Report of the Company on Form 10-K for the period ended December 31, 2011 as filed with the Securities and Exchange Commission on the date hereof and to which this Certificate is attached as Exhibit 32.2 (the “Report”), fully complies with the requirements of section 13(a) or 15(d) of the Exchange Act; and

(ii) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

In Witness Whereof, the undersigned have set their hands hereto as of the 12th day of March, 2012.

 

By:   /S/    JENNIFER LEW        
  Jennifer Lew
  Vice President, Finance
  (Principal Accounting and Financial Officer)

This certification accompanies the Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Dynavax Technologies Corporation under the Securities Act of 1933, as amended, or the Exchange Act (whether made before or after the date of the Form 10-K), irrespective of any general incorporation language contained in such filing.